logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
delete
arrow
返回
T

Tibor Szarvas

semmelweis university

35H指数
248论文数
3.4K被引数
收录论文 77
发表时间
logo
Comparative effectiveness of apalutamide-, abiraterone-, and enzalutamide-based doublets in mHSPC阿帕卢他胺、阿比特龙和恩扎卢他胺为基础的双药组合在mHSPC中的比较有效性
errBJU International
IF4.4
err2026-09-02
err0
errOAAI
errAnikó Katalin Valikovics; Dániel Bacsó; Nadeen Samaien; Isabel Pinto Amorim das Virgens; Mahmoud Obeidat; Gergely Bánfi; Boris Hadaschik; Péter Hegyi; Péter Nyirády; Tibor Szarvas
err分享
err收藏
Efficacy and Safety Differences Between Abiraterone and Enzalutamide in Patients with Metastatic Castration-Resistant Prostate Cancer: A Systematic Review and Meta-analysis of Real-World Studies阿比特龙和恩扎卢替尼在转移性去势抵抗性前列腺癌患者中的疗效和安全性差异：真实世界研究的系统评价和荟萃分析
errTargeted Oncology
IF4
err2026-06-29
err0
errOAAI
errAnikó Katalin Valikovics; Dániel Bacsó; Nadeen Samaien; Isabel Pinto Amorim das Virgens; Boglárka Szentes; Gergely Agócs; Mahmoud Obeidat; Tamás Széll; Boris Hadaschik; Péter Hegyi; Péter Nyirády; Tibor Szarvas
err分享
err收藏
MICROBIOME-DERIVED BIOMARKERS PREDICT RESPONSE TO IMMUNE CHECKPOINT INHIBITORS IN UROLOGIC MALIGNANCIES微生物组衍生的生物标志物预测泌尿系统恶性肿瘤对免疫检查点抑制剂的应答
errJournal of Urology
IF6.8
err2026-05-01
err0
PREAI
errMagyar, Balazs; Juhasz, Janos; Hermann-Varadi, Melinda; Horvath, Orsolya; Soos, Edina; Korda, Sara; Szucs, Miklos; Nyirady, Peter; Szarvas, Tibor
err分享
err收藏
CARDIOLOGIC AND ONCOLOGIC OUTCOMES WITH GLP-1 RECEPTOR AGONISTS IN MEN RECEIVING ANDROGEN DEPRIVATION THERAPY FOR PROSTATE CANCER在接受雄激素剥夺治疗的前列腺癌患者中，GLP-1受体激动剂的心血管和肿瘤学结局
errJournal of Urology
IF6.8
err2026-05-01
err0
PREAI
errFazekas, Tamas; Lenart, Adam; Ruppert, Mihaly; Blasszauer, Celia; Reibl, Daniel; Komka, Ida; Szalontai, Janos; Miszczyk, Marcin; Rajwa, Pawel; Hegyi, Peter; Szarvas, Tibor; Shariat, Shahrokh F.; Leapman, Michael S.; Nyirady, Peter
err分享
err收藏
EPIDEMIOLOGY AND REGIONAL VARIATION IN PROSTATE CANCER INCIDENCE AND TREATMENT IN HUNGARY匈牙利前列腺癌发病率和治疗的地流行病学及区域差异
errJournal of Urology
IF6.8
err2026-05-01
err0
PREAI
errLenart, Adam; Soos, Aron; Reibl, Daniel; Blasszauer, Celia; Komka, Ida; Horvath, Andras; Becsi, Aron; Leapman, Michael S.; Rajwa, Pawel; Shariat, Shahrokh F.; Hegyi, Peter; Szarvas, Tibor; Nyirady, Peter; Fazekas, Tamas
err分享
err收藏
Molecular subtype concordance and metastatic patterns in muscle-invasive bladder cancer肌层浸润性膀胱癌的分子亚型一致性及转移模式
errJournal of Pathology Clinical Research
IF3.7
err2026-03-27
err0
errOAAI
errOlah, Csilla; Juhasz, Daniel; Varadi, Melinda; Reis, Henning; Al-Nader, Mulham; Mahmoud, Osama; Grunwald, Barbara T.; Grunwald, Viktor; Hadaschik, Boris; Nyirady, Peter; Szarvas, Tibor
err分享
err收藏
Urachal cancer: a clinical, diagnostic, and therapeutic update脐尿管癌：临床、诊断和治疗进展
errCurrent Opinion in Urology
IF2.2
err2026-03-01
err3
PREAI
errReis, Henning; Szarvas, Tibor; Paner, Gladell P.
err分享
err收藏
Correction: Comparative proteome and serum analysis identified FSCN1 as a marker of abiraterone resistance in castration-resistant prostate cancer更正：比较蛋白质组学和血清分析鉴定了FSCN1作为去势抵抗性前列腺癌中阿比特龙耐药的标志物
errProstate Cancer and Prostatic Diseases
IF5.8
err2025-12-10
err0
errOAAI
errAnita Csizmarik; Nikolett Nagy; Dávid Keresztes; Melinda Váradi; Thilo Bracht; Barbara Sitek; Kathrin Witzke; Martin Puhr; Ilona Tornyi; József Lázár; László Takács; Gero Kramer; Sabina Sevcenco; Agnieszka Maj-Hes; Boris Hadaschik; Péter Nyirády; Tibor Szarvas
err分享
err收藏
Risk factors for vaginal wall erosion after pelvic organ prolapse surgery with implant: a systematic review and meta-analysis植入物辅助的盆腔器官脱垂手术术后阴道壁侵蚀的风险因素：一项系统评价和荟萃分析
errSCIENTIFIC REPORTS
IF3.9
err2025-11-19
err0
errOAAI
errAcs, Julia; Szabo, Anett; Fehervari, Peter; Skribek, Benjamin; Cavalcante, Bianca Golzio Navarro; Vancsa, Szilard; Romics, Miklos; Szarvas, Tibor; Nyirady, Peter; Acs, Nandor; Hegyi, Peter; Majoros, Attila
err分享
err收藏
Lymphovascular Invasion is Predictive for Adjuvant Platinum Therapy Benefit in Urothelial Bladder Cancer淋巴血管浸润是预测尿路上皮膀胱癌辅助铂类化疗获益的指标
errClinical Genitourinary Cancer
IF2.7
err2025-11-01
err0
errOAAI
errJuhasz, Daniel; Csizmarik, Anita; Varadi, Melinda; Bacso, Daniel; Kubik, Andras; Szucs, Miklos; Szekely, Eszter; Al-Nader, Mulham; Mahmoud, Osama; Krafft, Ulrich; Hadaschik, Boris; Nyirady, Peter; Szarvas, Tibor
err分享
err收藏
The Dublin International Society of Urological Pathology (ISUP) Consensus Conference on Best Practice Recommendations on the Pathology of Urachal Neoplasms都柏林国际泌尿病理学会（ISUP）关于尿囊肿瘤病理学最佳实践建议的共识会议
errAMERICAN JOURNAL OF SURGICAL PATHOLOGY
IF4.2
err2025-11-01
err3
PREAI
errReis, Henning; Al-Ahmadie, Hikmat; Gaisa, Nadine T.; Lopez-Beltran, Antonio; Maclean, Fiona; Tsuzuki, Toyonori; Werneck da Cunha, Isabela; Amin, Mahul B.; Aning, Jonathan; Aron, Manju; Athanazio, Daniel; Bambury, Richard M.; Cheng, Liang; Gopalan, Anuradha; Gulmann, Christian; Guo, Charles C.; Harris, Carole; Iyer, Gopa; Jimenez, Rafael E.; Jinzaki, Masahiro; Kikuchi, Eiji; Lal, Priti; Miyai, Kosuke; Netto, George J.; Pan, Chin-Chen; Panebianco, Valeria; van Rhijn, Bas W. G.; Siefker-Radtke, Arlene; Smith, Steven C.; Szarvas, Tibor; Wobker, Sara E.; Kristiansen, Glen; Paner, Gladell P.
err分享
err收藏
Clinical and Molecular Predictors of Response and Survival in Patients with Urothelial Carcinoma Treated with Enfortumab Vedotin: A Systematic Review and Meta-analysis接受恩富妥珠单抗治疗的尿路上皮癌患者的临床与分子预测因子：反应与生存的系统评价和荟萃分析
errEuropean Urology Open Science
IF4.5
err2025-10-31
err0
errOAAI
errMohammed Altenni; Péter Fehérvári; Jakub Hoferica; Péter Hegyi; Nándor Ács; Tamás Fazekas; Judit Vargha; Viktor Grünwald; Christopher Darr; Péter Riesz; Péter Nyirády; Tibor Szarvas
err分享
err收藏
Serum Markers as predictors for treatment benefit in castration-resistant prostate cancer血清标志物作为预测去势抵抗性前列腺癌治疗获益的指标
errUROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
IF2.3
err2025-09-01
err0
errOAAI
errSzarvas, Tibor; Kramer, Gero; Jagarlamudi, Kiran; Styrke, Johan; Linder, Stig
err分享
err收藏
Radical Surgery Compared to Bladder-Preserving Approaches for Limited Stage Small-Cell Bladder Cancer: Systematic Review and Meta-Analysis根治性手术与保留膀胱方法治疗局限期小细胞膀胱癌的比较：系统评价与Meta分析
errCLINICAL GENITOURINARY CANCER
IF0
err2025-09-01
err0
errOAAI
errKubik, Andras; Virgens, Isabel Pinto Amorim das; Varga, Nora; Szabo, Anett; Keszthelyi, Attila; Fehervari, Peter; Hegyi, Peter; Acs, Nandor; Nyirady, Peter; Szarvas, Tibor
err分享
err收藏
Real-World Overall Survival Comparison of Enzalutamide and Abiraterone In First- and Second-Line Setting of Metastatic Castration-Resistant Prostate Cancer真实世界总生存比较：恩扎卢胺与阿比特龙在转移性去势抵抗性前列腺癌的一线和二线治疗中的应用
errprostate
IF0
err2025-06-08
err0
errOAAI
errAndrás Horváth; Celia Blasszauer; Ida Komka; Dániel Reibl; Boris Hadaschik; Tamás Fazekas; Pawel Rajwa; Àron Soós; Anikó Valikovics; Péter Nyirády; Tibor Szarvas
err分享
err收藏
Multitracer comparison of gold standard PSMA-PET/CT with 68Ga-FAPI and 18F-FDG in high-risk prostate cancer: a proof-of-concept study多示踪剂比较金标准PSMA-PET/CT与68Ga-FAPI和18F-FDG在高风险前列腺癌中的应用：一项概念验证研究
errEUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
IF7.6
err2025-05-27
err0
PREAI
errMahmoud, Osama; Pullen, Lukas; Umutlu, Lale; Szarvas, Tibor; Fendler, Wolfgang P.; Ting, Saskia; Reis, Henning; Bayer, Henning; Herrmann, Ken; Hadaschik, Boris A.; Al-Nader, Mulham; Berliner, Christoph
err分享
err收藏
Melanoma Proteomics Unveiled: Harmonizing Diverse Data Sets for Biomarker Discovery and Clinical Insights via MEL-PLOT黑色素瘤蛋白质组学解析：通过MEL-PLOT协调多样化数据集以发现生物标志物并获得临床洞见
errJOURNAL OF PROTEOME RESEARCH
IF3.6
err2025-05-05
err1
errOAAI
errBartha, Aron; Weltz, Boglarka; Betancourt, Lazaro Hiram; Gil, Jeovanis; de Almeida, Natalia Pinto; Bianchini, Giampaolo; Szeitz, Beata; Szadai, Leticia; Pla, Indira; Kemeny, Lajos; Janosi, Agnes Judit; Hong, Runyu; Rajeh, Ahmad; Nogueira, Fabio; Doma, Viktoria; Woldmar, Nicole; Guedes, Jessica; Ujfaludi, Zsuzsanna; Kim, Yonghyo; Szarvas, Tibor; Pahi, Zoltan; Pankotai, Tibor; Szasz, A. Marcell; Sanchez, Aniel; Baldetorp, Bo; Timar, Jozsef; Nemeth, IstvanBalazs; Karpati, Sarolta; Appelqvist, Roger; Domont, Gilberto Barbosa; Pawlowski, Krzysztof; Wieslander, Elisabet; Malm, Johan; Fenyo, David; Horvatovich, Peter; Marko-Varga, Gyorgy; Gyorffy, Balazs
err分享
err收藏
Androgen Receptor Pathway Inhibitor Monotherapy in Prostate Cancer: Safety, Oncologic Outcomes, and Quality of Life—A Systematic Review and Meta-analysis雄激素受体通路抑制剂单药治疗在前列腺癌中的应用：安全性、肿瘤学结局及生活质量——一项系统评价和Meta分析
errEuropean Urology Focus
IF5.6
err2025-05-01
err0
errOAAI
errTamás Fazekas; Marcin Miszczyk; Alexander Giesen; Tamás Kói; Fabio Zattoni; Lara Rodriguez-Sanchez; Takafumi Yanagisawa; Akihiro Matsukawa; Tibor Szarvas; Piotr Kryst; Juan Gómez Rivas; Axel S. Merseburger; Maria De Santis; Steven Joniau; Alberto Briganti; Giancarlo Marra; Péter Nyirády; Giorgio Gandaglia; Shahrokh F. Shariat; Pawel Rajwa
err分享
err收藏
Assessing the efficacy of varicocelectomy, antioxidants, FSH treatment, and lifestyle modifications on sperm DNA fragmentation: a systematic review and meta-analysis评估精索静脉曲张切除术，抗氧化剂，FSH治疗和生活方式改变对精子DNA碎片的疗效: 系统回顾和荟萃分析
errSCIENTIFIC REPORTS
IF3.9
err2025-03-24
err0
errOAAI
errSzabo, Anett; Vancsa, Szilard; Hegyi, Peter; Koi, Tamas; Acs, Julia; Hermanne, Reka Juhasz; Acs, Nandor; Szarvas, Tibor; Nyirady, Peter; Kopa, Zsolt
err分享
err收藏
Prognostic and predictive value of pre-treatment blood-based inflammatory biomarkers in patients with urothelial carcinoma treated with immune checkpoint inhibitors: a systematic review and meta-analysis尿路上皮癌患者接受免疫检查点抑制剂治疗时，治疗前血液炎症生物标志物的预后和预测价值：一项系统评价和荟萃分析
errFRONTIERS IN IMMUNOLOGY
IF5.9
err2025-03-17
err0
errOAAI
errSzeles, Adam; Kubik, Andras; Vancsa, Szilard; Gruenwald, Viktor; Hadaschik, Boris; Acs, Nandor; Hegyi, Peter; Nyirady, Peter; Szarvas, Tibor
err分享
err收藏

研究方向

暂时未获取到该数据
合作学者
合作期刊
S
Shahrokh F. Shariat
H 指数: 146 · 论文数: 2.9K
M
Martin Gleave
H 指数: 126 · 论文数: 1.8K
C
Csaba P. Kövesdy
H 指数: 125 · 论文数: 1.0K
U
Uwe Haberkorn
H 指数: 108 · 论文数: 760
H
Hikmat Al‐Ahmadie
H 指数: 106 · 论文数: 808
查看更多